Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference55 articles.
1. Alamgeer M, Ganju V, Kumar B et al. (2014) Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer breast cancer research : BCR 16:R44, doi: https://doi.org/10.1186/bcr3648
2. Alamgeer M, Ganju V, Szczepny A et al (2013) The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer. Thorax 68:1095–1104. https://doi.org/10.1136/thoraxjnl-2012-203021
3. Allard WJ, Matera J, Miller MC et al (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clinical cancer research : an official journal of the American Association for Cancer Research 10:6897–6904. https://doi.org/10.1158/1078-0432.CCR-04-0378
4. Ando M, Kobayashi K, Yoshimura A et al (2004) Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer. Lung Cancer 44:121–127. https://doi.org/10.1016/j.lungcan.2003.10.003
5. Ardizzoni A, Manegold C, Debruyne C et al (2003) European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 9:143–150
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献